SDR16C6, which stands for "Short Chain Dehydrogenase/Reductase Family 16C, Member 6," is part of the SDR family of enzymes. It is characterized by its role in oxidoreduction reactions where it catalyzes the NAD(P)(H)-dependent oxidation or reduction of substrates with a relatively short-chain length. SDR16C6, like other members of the SDR family, is involved in a myriad of metabolic processes which can include the metabolism of steroids, fatty acids, and xenobiotics.The SDR enzymes are known for their conserved structural motif, often referred to as the Rossmann fold, which is essential for binding the coenzyme NAD(P)(H). This motif is a key feature that allows these enzymes to participate in the electron transfer required for their catalytic activity. The precise function of SDR16C6, in terms of its specific substrates and biological roles, is not as well characterized as other members of the SDR family.
Nevertheless, the enzymatic activity of SDR16C6 suggests it may play a role in the metabolism of hormones or signaling molecules, contributing to the regulation of various physiological pathways. Changes in the expression or activity of SDR16C6 could feasibly influence metabolic balance, and an understanding of its function might shed light on certain metabolic disorders or contribute to the development of drugs targeting specific metabolic pathways.It's also important to note that SDR enzymes, in general, can be subject to regulation by various cellular factors and might be involved in the cellular response to external stimuli, including drugs and environmental factors. As such, SDR16C6 may also be part of the broader network of enzymes that help maintain cellular homeostasis by modulating metabolic pathways in response to changing cellular needs and conditions.
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
포도당 대사를 조절하는 항당뇨병 약물로, 잠재적으로 SDR16C6과 관련된 경로에 영향을 미칠 수 있습니다. | ||||||
Insulin 항체 () | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
포도당과 지질 대사의 주요 조절자인 인슐린은 SDR16C6 활성에 간접적으로 영향을 미칠 수 있습니다. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
PPARγ 작용제는 지질과 포도당 대사에 영향을 미쳐 잠재적으로 SDR16C6에 영향을 미칠 수 있습니다. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
또 다른 PPARγ 작용제는 지질과 포도당 대사를 변화시켜 SDR16C6에 영향을 줄 수 있습니다. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $222.00 $593.00 | 1 | |
알파-글루코시다제 억제제는 탄수화물 대사에 영향을 미쳐 잠재적으로 SDR16C6에 영향을 미칠 수 있습니다. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
페노피브레이트는 PPARα 작용제로서 지질 대사를 조절하여 잠재적으로 SDR16C6에 영향을 미칠 수 있습니다. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
지질 대사에 영향을 미쳐 잠재적으로 SDR16C6 관련 경로에 영향을 미칠 수 있습니다. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
콜레스테롤 대사에 영향을 미치는 스타틴으로, 잠재적으로 SDR16C6에 영향을 미칠 수 있습니다. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $51.00 | 7 | |
리파아제를 억제하여 지질 소화 및 흡수에 영향을 미치고 잠재적으로 SDR16C6에 영향을 미칩니다. |